PPARG, peroxisome proliferator activated receptor gamma, 5468
N. diseases: 877; N. variants: 101
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 3 | 12347064 | intron variant | A/C | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 12385437 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 3 | 12303137 | intron variant | A/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 3 | 12311827 | intron variant | T/C | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.120 | 3 | 12404308 | intron variant | C/A | snv | 0.70 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 3 | 12405654 | intron variant | G/T | snv | 0.61 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.120 | 3 | 12295008 | intron variant | G/A | snv | 8.8E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.120 | 3 | 12295008 | intron variant | G/A | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.120 | 3 | 12295008 | intron variant | G/A | snv | 8.8E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 12302092 | intron variant | G/A | snv | 0.28 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 12303231 | intron variant | C/G | snv | 9.2E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.120 | 3 | 12311472 | intron variant | C/G | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 |